ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)
$48.03 0.13 (0.2714%)
Analysed ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) News Sources
Royalty Pharma plc (RPRX) Proved Resilience in Q1 by Gaining 25.6%
13-04-2026
yahoo.com
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
13-04-2026
yahoo.com
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
10-04-2026
yahoo.com
Branded Pharmaceuticals Stocks Q4 Teardown: Royalty Pharma (NASDAQ:RPRX) Vs The Rest
08-04-2026
yahoo.com
Assessing Royalty Pharma (RPRX) Valuation After Strong Recent Share Price Momentum
05-04-2026
yahoo.com
1 Value Stock for Long-Term Investors and 2 Facing Challenges
03-04-2026
yahoo.com
Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal
02-04-2026
yahoo.com
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
01-04-2026
yahoo.com
1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm
31-03-2026
yahoo.com
Johnson & Johnson’s JNJ-4804 Deal Adds Weight To Immunology Story
30-03-2026
yahoo.com
What is the current price of ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)?
The current price of ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) is $48.03.
ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) since the previous trading day is $0.13.
ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) since the previous trading day is 0.2714%.
What is the most recent average sentiment score for ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)?
The most recent average sentiment score for ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)?
The most recent sentiment for ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ) is .
SEC-8K** Filing Available For ROYALTY PHARMA PLC- CL A (RPRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.